ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ZTS Zoetis Inc

149.25
3.71 (2.55%)
After Hours
Last Updated: 16:32:33
Delayed by 15 minutes

Period:

Draw Mode:

Volume 4,072,716
Bid Price
Ask Price
News -
Day High 149.8989

Low
144.80

52 Week Range

High
201.92

Day Low 145.18
Company Name Stock Ticker Symbol Market Type
Zoetis Inc ZTS NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
3.71 2.55% 149.25 16:32:33
Open Price Low Price High Price Close Price Prev Close
146.25 145.18 149.8989 149.56 145.54
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
50,805 4,072,716 $ 148.17 $ 603,457,629 - 144.80 - 201.92
Last Trade Time Type Quantity Stock Price Currency
16:32:33 formt 475 $ 149.25 USD

Zoetis (ZTS) Options Flow Summary

Overall Flow

Bearish

Net Premium

-1M

Calls / Puts

56.52%

Buys / Sells

65.00%

OTM / ITM

50.00%

Sweeps Ratio

0.00%

Zoetis Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
68.09B 457.87M - 8.54B 2.34B 5.12 29.05
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Zoetis News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ZTS Message Board. Create One! See More Posts on ZTS Message Board See More Message Board Posts

Historical ZTS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week150.78154.40144.80149.754,756,925-1.53-1.01%
1 Month169.21171.14144.80156.844,139,851-19.96-11.80%
3 Months192.87200.5341144.80173.183,436,660-43.62-22.62%
6 Months166.58201.92144.80175.892,657,182-17.33-10.40%
1 Year176.99201.92144.80176.452,252,831-27.74-15.67%
3 Years169.00249.27124.1483177.812,044,361-19.75-11.69%
5 Years100.26249.2790.14160.822,034,13948.9948.86%

Zoetis Description

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Your Recent History

Delayed Upgrade Clock